Search by Drug Name or NDC

    NDC 69097-0374-15 Tadalafil 5 mg/1 Details

    Tadalafil 5 mg/1

    Tadalafil is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is TADALAFIL.

    Product Information

    NDC 69097-0374
    Product ID 69097-374_92ec5f3d-f54d-4f28-bac6-b606c99b17c9
    Associated GPIs 40304080000305
    GCN Sequence Number 053296
    GCN Sequence Number Description tadalafil TABLET 5 MG ORAL
    HIC3 F2A
    HIC3 Description DRUGS TO TREAT ERECTILE DYSFUNCTION (ED)
    GCN 20736
    HICL Sequence Number 024859
    HICL Sequence Number Description TADALAFIL
    Brand/Generic Generic
    Proprietary Name Tadalafil
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tadalafil
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name TADALAFIL
    Labeler Name Cipla USA Inc.
    Pharmaceutical Class Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209539
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0374-15 (69097037415)

    NDC Package Code 69097-374-15
    Billing NDC 69097037415
    Package 1000 TABLET, FILM COATED in 1 BOTTLE (69097-374-15)
    Marketing Start Date 2019-03-26
    NDC Exclude Flag N
    Pricing Information N/A